Login / Signup

In Silico Predicted Antifungal Peptides: In Vitro and In Vivo Anti-Candida Activity.

Tecla CiociolaWalter MaglianiTiziano De SimoneThelma A PertinhezStefania ContiGiorgio CozzaOriano MarinLaura Giovati
Published in: Journal of fungi (Basel, Switzerland) (2021)
It has been previously demonstrated that synthetic antibody-derived peptides could exert a significant activity in vitro, ex vivo, and/or in vivo against microorganisms and viruses, as well as immunomodulatory effects through the activation of immune cells. Based on the sequence of previously described antibody-derived peptides with recognized antifungal activity, an in silico analysis was conducted to identify novel antifungal candidates. The present study analyzed the candidacidal and structural properties of in silico designed peptides (ISDPs) derived by amino acid substitutions of the parent peptide KKVTMTCSAS. ISDPs proved to be more active in vitro than the parent peptide and all proved to be therapeutic in Galleria mellonella candidal infection, without showing toxic effects on mammalian cells. ISDPs were studied by circular dichroism spectroscopy, demonstrating different structural organization. These results allowed to validate a consensus sequence for the parent peptide KKVTMTCSAS that may be useful in the development of novel antimicrobial molecules.
Keyphrases
  • amino acid
  • candida albicans
  • molecular docking
  • staphylococcus aureus
  • high resolution
  • single molecule
  • pseudomonas aeruginosa
  • solid state